HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pectin and pectic-oligosaccharides induce apoptosis in in vitro human colonic adenocarcinoma cells.

AbstractBACKGROUND:
Dietary fibres have been associated with decreased risk of various cancers, although the mechanisms are unclear. Induction of apoptosis in tumour cells is thought to be an important protective mechanism against colorectal cancer. This work investigates the effects of pectins and pectic-oligosaccharides (POS) on the human colonic adenocarcinoma cell line HT29.
MATERIALS AND METHODS:
The anti-proliferative effects of pectin and POS were studied by testing the HT29 cells for cytotoxicity, differentiation and/or apoptosis by lactate dehydrogenase, alkaline phosphatase and caspase-3 activity assays. DNA agarose gel electrophoresis was also carried out.
RESULTS:
A significant reduction in attached cell numbers was observed after three days incubation. This decrease was neither due to cells undergoing necrosis nor differentiation. Increased apoptosis frequency, after incubation with 1% (w/v) pectin and/or POS, was demonstrated by caspase-3 activity and DNA laddering on agarose gel electrophoresis.
CONCLUSION:
Dietary pectins and their degradation products may contribute to the reported protective effects of fruits against colon cancer.
AuthorsEstibaliz Olano-Martin, Gerald H Rimbach, Glenn R Gibson, Robert A Rastall
JournalAnticancer research (Anticancer Res) 2003 Jan-Feb Vol. 23 Issue 1A Pg. 341-6 ISSN: 0250-7005 [Print] Greece
PMID12680234 (Publication Type: Journal Article)
Chemical References
  • Oligosaccharides
  • Pectins
  • CASP3 protein, human
  • Caspase 3
  • Caspases
Topics
  • Adenocarcinoma (drug therapy, enzymology, pathology)
  • Apoptosis (drug effects)
  • Caspase 3
  • Caspases (metabolism)
  • Cell Division (drug effects)
  • Colonic Neoplasms (drug therapy, enzymology, pathology)
  • HT29 Cells
  • Humans
  • Oligosaccharides (pharmacology)
  • Pectins (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: